Professor, Internal Medicine, Mayo Medical School
Internal Medicine
Dr. Richard D. Hurt, MD
|
|
Give Review
Doctor Richard D. Hurt, MD practices Internal Medicine. He went to medical school at University of Louisville School of Medicine. University of Louisville School of Medicine is ranked 83 in research and 0 in primary care medicine He over the years received 1 awards: "Fellow (FASAM)". Richard D. Hurt is also published. He has 53 publications published. The lastest publication: "Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.' Richard D. Hurt, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
- Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws.
- Tobacco dependence counseling in a randomized multisite clinical trial.
- Preventing lung cancer by treating tobacco dependence.
- Roadmap to a tobacco epidemic: transnational tobacco companies invade Indonesia.
- Residential treatment compared with outpatient treatment for tobacco use and dependence.
- Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.
- Willingness of cancer patients to help family members to quit smoking.
- Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States.
- The role of smoking in breast cancer development: an analysis of a Mayo Clinic cohort.
- Treating tobacco dependence in a medical setting.
- Focus groups of Alaska Native adolescent tobacco users: preferences for tobacco cessation interventions and barriers to participation.
- Open doorway to truth: legacy of the Minnesota tobacco trial.
- "Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China.
- Urinary tobacco alkaloid measurement in patients having thromboangiitis obliterans.
- Waking a sleeping giant: the tobacco industry's response to the polonium-210 issue.
- Tobacco use and cessation among pregnant Alaska Natives from Western Alaska enrolled in the WIC program, 2001-2002.
- Development and feasibility of a parental support intervention for adolescent smokers.
- Change in perceived stress, partner support, decisional balance, and self-efficacy following residential nicotine dependence treatment.
- Second primary tumors following tobacco dependence treatments among head and neck cancer patients.
- Tobacco and other substance use among Alaska Native youth in western Alaska.
- Treating tobacco dependence: review of the best and latest treatment options.
- Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
- Validation of the revised Self-Administered Alcohol Screening Test (SAAST-R).
- Characteristics of six-month tobacco use outcomes of Black patients seeking smoking cessation intervention.
- Is smoking related to body image satisfaction, stress, and self-esteem in young adults?
- A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's Disease).
- Expressive writing intervention for young adult cigarette smokers.
- Iqmik: a form of smokeless tobacco used among Alaska natives.
- Treating nondepressed smokers with alcohol dependence in sustained full remission: nicotine patch therapy tailored to baseline serum cotinine.
- Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening.
- Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonates.
- Tobacco use during pregnancy among Alaska Natives in western Alaska.
- Revision of the Self-Administered Alcoholism Screening Test (SAAST-R): a pilot study.
- Personality correlates related to tobacco abstinence following treatment.
- Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
- Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
- A cigarette manufacturer and a managed care company collaborate to censor health information targeted at employees.
- Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: a matched-pair analysis.
- Residential treatment for smokeless tobacco use: a case series.
- Focus groups of Y-K Delta Alaska Natives: attitudes toward tobacco use and tobacco dependence interventions.
- Change in smoking status after spiral chest computed tomography scan screening.
- Differences in adolescent smoker and nonsmoker perceptions of strategies that would help an adolescent quit smoking.
- Depressed versus nondepressed young adult tobacco users: differences in coping style, weight concerns and exercise level.
- Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
- Relationship of tobacco use to depressive disorders and suicidality among patients treated for alcohol dependence.
- Treatment of tobacco dependence in alcoholics.
- The effect of nicotine patch therapy on depression in nonsmokers: a preliminary study.
- Pharmacotherapy for alcoholic smokers.
- Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles.
- Tobacco use outcomes among patients with lung cancer treated for nicotine dependence.
- Preventing lung cancer by stopping smoking.
Schools
University of Louisville School of Medicine
Baptist Memorial Hospital Memphis
Mayo Grad School
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Fellow (FASAM)
Education
-
Mayo School of Graduate Medical Education -
University of Louisville School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1184697724 | |
| NPPES Provider LastName | HURT | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 150.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184697724 |
| Last Name Of The Provider | HURT |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
|
Dr. Sara M. May, MD |
|
|
Dr. Jon C. Tilburt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clayton M. Spiceland, MD |
|
|
Dr. Anthony A. Razzak, MD |
|
|
Dr. Andrew I. Vaughn, MD |
|
|
Dr. Sara L. Reppert, MD |
|
|
Dr. Byron L. Riggs Jr., MD
This Doctor is OpenDoctor Recommended.
|